NCT00380601 - PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

February 28, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

MRA(Tocilizumab)

8mg/kg/4 weeks

Trial Locations (10)

Chugoku region, Chugoku

Chukyo region, Chukyo

Hokkaido region, Hokkaido

Hokuriku region, Hokuriku

Kansai region, Kansai

Kanto region, Kanto

Kousinetsu region, Kousinetsu

Kyushu region, Kyushu

Sikoku region, Sikoku

Tohoku region, Tōhoku